Eli Lilly and Company vs Merck & Co. Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Healthcare sector.
| Metric | Eli Lilly and Company (LLY) | Merck & Co. Inc. (MRK) |
|---|---|---|
| Operator Signal | Tailwind | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $19.8B | $16.3B |
| Revenue Growth | 73.1%* | -2.2% |
| Latest EPS | $8.26* | $-1.72 |
| EPS Growth | 672.0%* | -238.7% |
| Sector | Healthcare | Healthcare |
| Quarters Tracked | 8 | 8 |
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Healthcare sector.